1. US Food and Drug Administration. Premarket approval application (PMA) for Medtronic, Inc.’s Symplicity Spyral Radiofrequency Renal Denervation System: Circulatory System Devices Advisory Committee Meeting, August 23, 2023. https://www.fda.gov/media/171690/download (accessed 1 December, 2023).
2. US Centers for Disease Control and Prevention. Estimated hypertension prevalence, treatment, and control among U.S. adults. 2023. https://millionhearts.hhs.gov/data-reports/hypertension-prevalence.html (accessed 29 August, 2023).
3. Trends in blood pressure control among us adults with hypertension, 1999-2000 to 2017-2018;Muntner;JAMA,2020
4. Renal denervation: a review;Rey-Garcia;Am J Kidney Dis,2022
5. Randomized blinded placebo-controlled trials of renal sympathetic denervation for hypertension: a meta-analysis;Ahmad;Cardiovasc Revasc Med,2022